dr. bunn discusses afatinib in lung cancer
Published 10 years ago • 516 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:35
dr. bunn discusses afatinib for patients with egfr mutation
-
3:22
dr. bunn discusses the need to study drug combinations in lung cancer
-
1:31
dr. bunn on combining immunotherapy and chemotherapy in lung cancer
-
1:29
dr. bunn on the response of immunotherapy in lung cancer
-
0:58
the activity of afatinib in lung cancer
-
2:51
dr. bunn discusses the potential benefit for a blood-based test to detect a t790m mutation
-
8:38
afatinib plus cetuximab in resistant non-small cell lung cancer
-
1:35
dr. janjigian discusses afatinib and cetuximab for patients with egfr-mutant lung cancer
-
1:53
dr. mok on the utility of afatinib in lung cancer
-
0:45
dr. corey langer discusses afatinib in egfr-positive nsclc
-
1:25
dr. chachoua on afatinib for exon 19 mutation in lung cancer
-
3:47
afatinib therapy for uncommon egfr alterations in nsclc
-
0:51
dr. west discusses afatinib and cetuximab combination in nsclc
-
4:09
frontline afatinib in egfr-mutant nsclc
-
1:30
dr. langer on afatinib for advanced non-small cell lung cancer
-
1:59
dr. tolba on the use of afatinib in nrg1-mutated lung adenocarcinoma
-
1:47
dr. west on fda approval of afatinib in nsclc with rare egfr mutations
-
4:06
afatinib in patients with uncommon egfr mutations
-
1:25
dr. giorgio scagliotti discusses afatinib in patients with egfr mutation